Seeking Alpha

QCOR
  Questcor Pharmaceuticals, Inc. - NASDAQ

10/31/2014, 5:01 PM ET
  • Holly Thompson | Send Message 30 Oct 2013

    Questcor $QCOR reports earnings of $1.52/sh, $.32 better than consensus of $1.20; revs rose 68.4% yr/yr to $236.4M vs the $199.8M consensus.
    Reply
      QCOR vs. ETF Alternatives
      Company Description
      Questcor Pharmaceuticals Inc is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune & inflammatory disorders.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States